Skip to main content
Category

Cardiovascular Science and Diabetes Program

Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area

Phase 3 drug trial for rare chronic kidney disease achieves key milestone

By | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research Area

Biopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…

Cardiovascular DiseaseCardiovascular DiseaseCardiovascular Science and Diabetes ProgramDiabetesFundingNews & EventsResearch

Federal government supports new treatment to clear blocked arteries

By | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, Research

A Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…

Biomedical engineeringCardiovascular DiseaseCardiovascular DiseaseHeartMedia ReleasesNews & EventsT3mPLATE LaboratoryVascular Engineering

3D Printed heart valves to be commercialised

By | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, T3mPLATE Laboratory, Vascular Engineering

Cutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…

Bioimaging Research and Innovation for Translational Engingeering BRITEFundingImaging and TherapyMedia ReleasesNews & Events

Perth MedTech firm secures funding for cannula innovation

By | Bioimaging Research and Innovation for Translational Engingeering BRITE, Funding, Imaging and Therapy, Media Releases, News & Events

VeinTech awarded $493,489 of Accelerating Commercialisation funding Perth based medical device company VeinTech is excited to announce it has secured $493,489 of matched non-dilutive funding to continue its efforts to…